WeVote
Log In

Bill

Bill

HB 1162

Correctional Services – Medication–Assisted Treatment Funding

2026 Regular Session Introduced by Tiffany Alston

Maryland bill authorizes funding for medication-assisted opioid addiction treatment in correctional facilities to reduce recidivism and improve health outcomes.

Hearing 3/10 at 1:00 p.m. (Health)
0
WeVote Research Nonpartisan
Bill Summary · HB 1162

Legislative bill overview

HB 1162 would establish or expand funding mechanisms for medication-assisted treatment (MAT) programs within Maryland's correctional facilities. The bill addresses opioid addiction treatment for incarcerated individuals by allocating resources to provide medications like methadone or buprenorphine alongside counseling services.

Why is this important

Opioid addiction is prevalent in correctional settings, and untreated addiction increases relapse and recidivism rates upon release. Providing MAT during incarceration can improve health outcomes, reduce overdose deaths, and lower recidivism—benefiting both formerly incarcerated individuals and public safety outcomes.

Potential points of contention

  • Cost and budget priorities: Funding MAT programs requires state resources that could be allocated elsewhere; fiscal impact on corrections budgets remains unclear
  • Implementation logistics: Correctional facilities may lack infrastructure, trained staff, or security protocols to safely administer and monitor controlled medications
  • Philosophical debate: Disagreement exists over whether incarceration should prioritize treatment versus punishment, and whether medication-based approaches are appropriate in custodial settings

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.